QNTM vs. SMHX
QNTM (Quantum BioPharma Ltd) is a stock, while SMHX (VanEck Fabless Semiconductor ETF) is Semiconductors fund tracking the MarketVector™ US Listed Fabless Semiconductor Index. Over the past year, QNTM returned -87.81% vs 64.03% for SMHX. Their 0.14 correlation means their historical movements had little consistent relationship.
Performance
QNTM vs. SMHX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, QNTM achieves a -60.41% return, which is significantly lower than SMHX's 44.20% return.
QNTM
- 1D
- 1.76%
- 1M
- -17.66%
- 6M
- -36.90%
- YTD
- -60.41%
- 1Y
- -87.81%
- 3Y*
- -67.70%
- 5Y*
- -52.03%
- 10Y*
- —
- ALL TIME*
- -51.98%
SMHX
- 1D
- 1.69%
- 1M
- -6.50%
- 6M
- 40.29%
- YTD
- 44.20%
- 1Y
- 64.03%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 49.51%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $262.51K | $263.06K | $1.42M | |
| $4.68M | $6.01M | $8.35M |
QNTM vs. SMHX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
QNTM Quantum BioPharma Ltd | -60.41% | 98.37% | -16.36% |
SMHX VanEck Fabless Semiconductor ETF | 44.20% | 30.00% | 15.56% |
Correlation
The correlation between QNTM and SMHX is 0.11, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.11 |
Correlation (All Time) Calculated using the full available price history since Aug 28, 2024 | 0.14 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QNTM vs. SMHX — Risk / Return Rank
QNTM
SMHX
QNTM vs. SMHX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Quantum BioPharma Ltd (QNTM) and VanEck Fabless Semiconductor ETF (SMHX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| QNTM | SMHX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.15 | ||
| Sortino ratioReturn per unit of downside risk | -3.34 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.26 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | -0.95 | 2.46 | -3.41 |
| Martin ratioReturn relative to average drawdown | -1.19 | 7.67 | -8.86 |
Loading charts...
Drawdowns
QNTM vs. SMHX - Drawdown Comparison
The maximum QNTM drawdown since its inception was -99.98%, which is greater than SMHX's maximum drawdown of -38.53%. Use the drawdown chart below to compare losses from any high point for QNTM and SMHX.
Loading charts...
Drawdown Indicators
| QNTM | SMHX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.98% | -38.53% | -61.45% |
Max Drawdown (1Y)Largest decline over 1 year | -92.81% | -24.93% | -67.88% |
Max Drawdown (3Y)Largest decline over 3 years | -97.98% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -98.42% | — | — |
Current DrawdownCurrent decline from peak | -99.97% | -19.19% | -80.78% |
Average DrawdownAverage peak-to-trough decline | -92.34% | -7.72% | -84.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 73.68% | 7.99% | +65.69% |
Volatility
QNTM vs. SMHX - Volatility Comparison
Quantum BioPharma Ltd (QNTM) has a higher volatility of 16.50% compared to VanEck Fabless Semiconductor ETF (SMHX) at 14.74%. This indicates that QNTM's price experiences larger fluctuations and is considered to be riskier than SMHX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QNTM | SMHX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.50% | 14.74% | +1.76% |
Volatility (6M)Calculated over the trailing 6-month period | 106.32% | 33.37% | +72.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 146.13% | 39.65% | +106.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 134.30% | 42.00% | +92.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 139.57% | 42.00% | +97.57% |
Dividends
QNTM vs. SMHX - Dividend Comparison
QNTM has not paid dividends to shareholders, while SMHX's dividend yield for the trailing twelve months is around 0.02%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
QNTM Quantum BioPharma Ltd | 0.00% | 0.00% | 0.00% |
SMHX VanEck Fabless Semiconductor ETF | 0.02% | 0.02% | 0.04% |
Frequently Asked Questions
QNTM and SMHX have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QNTM has higher volatility (16.50%) compared to SMHX (14.74%). In terms of maximum drawdown, QNTM dropped -99.98% vs SMHX's -38.53%.
SMHX currently has the higher Sharpe Ratio (1.55 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for QNTM and SMHX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer